Figure INF-11: Trends in prevalence of markers of HBV infection estimated from national and sub-national samples of injecting drug users 1995 to 2004, where data are available – Part (i) Injecting drug users aHBc positive (ever infected)

Notes:

Seroprevalence studies (SP) data from diagnostic testing (DT).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national focal points.